News
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
In proof that you can’t make everyone happy all of the time, soda fans are rebelling against a new Dr Pepper flavor.
Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised ...
(WJW) – More than 14,000 packs of ‘cough, cold & flu’ medicine are being recalled over a risk of child poisoning, according to the U.S. Consumer Product Safety Commission. The recall applies ...
Whooping cough, known clinically as pertussis, has caused the death of at least five, according to a ProPublica report, and cases skyrocketed by 1,500% nationwide since a 2021 low point ...
Parents at Del Valle Early College High School were notified by Austin Public Health of a case of pertussis. The infectious ...
Anyone in the U.S. who bought any flavor Robitussin product containing dextromethorphan (or DXM) and labeled as “non-drowsy” between Feb. 16, 2016, and Jan. 21 are eligible to file a claim, according ...
A measles outbreak has been keeping American health care professionals on their toes, but experts say we should also be wary of another preventable disease: whooping cough. This illness typically ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results